Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma

Aritro Nath; Irene Li; Lewis R. Roberts; Christina Chan

doi:10.1038/srep14752

Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma

Aritro Nath, Irene Li, Lewis R. Roberts, Christina Chan

Gastroenterology and Hepatology

Research output: Contribution to journal › Article › peer-review

134 Scopus citations

Abstract

Hepatocellular carcinoma (HCC) is the second-leading cause of cancer-related death worldwide, and the factors influencing HCC progression are poorly understood. Here we reveal that HCC progression via induction of epithelial-mesenchymal transition (EMT) is closely associated with the expression of CD36/fatty acid translocase and elevated free fatty acid (FFA) levels. Although obesity is manifested as elevated FFA levels, the degree of EMT was not associated with the body mass index of the patients, highlighting the specific roles of CD36 and FFA uptake. Treatment of human liver cancer cell lines with FFAs exacerbated the EMT phenotype, whereas chemical inhibition of CD36 mitigated these effects. Furthermore, the Wnt and TGF-β signaling pathways were activated upon FFA treatment, potentially acting as upstream activators of the EMT program. These results provide the first direct evidence associating CD36 and elevated FFAs with HCC progression.

Original language	English (US)
Article number	14752
Journal	Scientific reports
Volume	5
DOIs	https://doi.org/10.1038/srep14752
State	Published - Oct 1 2015

ASJC Scopus subject areas

General

Access to Document

10.1038/srep14752

Cite this

@article{547e0773ec1541b688db81a1d4847993,

title = "Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma",

abstract = "Hepatocellular carcinoma (HCC) is the second-leading cause of cancer-related death worldwide, and the factors influencing HCC progression are poorly understood. Here we reveal that HCC progression via induction of epithelial-mesenchymal transition (EMT) is closely associated with the expression of CD36/fatty acid translocase and elevated free fatty acid (FFA) levels. Although obesity is manifested as elevated FFA levels, the degree of EMT was not associated with the body mass index of the patients, highlighting the specific roles of CD36 and FFA uptake. Treatment of human liver cancer cell lines with FFAs exacerbated the EMT phenotype, whereas chemical inhibition of CD36 mitigated these effects. Furthermore, the Wnt and TGF-β signaling pathways were activated upon FFA treatment, potentially acting as upstream activators of the EMT program. These results provide the first direct evidence associating CD36 and elevated FFAs with HCC progression.",

author = "Aritro Nath and Irene Li and Roberts, {Lewis R.} and Christina Chan",

note = "Funding Information: We thank Dr. Melinda Frame at Center for Advanced Microscopy, Michigan State University for assistance with confocal experiments, Dr. Louis King and Christi Harris at Flow Cytometry Core, Michigan State University for assistance with flow cytometry experiments. We thank Catherine D. Moser and Nasra H. Giama at the Mayo Clinic for assistance with the provision of de-identified frozen tissue samples and their corresponding clinical information. This study was supported in part by the National Science Foundation (CBET 0941055) and the National Institutes of Health (R01GM089866 and R21CA176854).",

year = "2015",

month = oct,

day = "1",

doi = "10.1038/srep14752",

language = "English (US)",

volume = "5",

journal = "Scientific reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma

AU - Nath, Aritro

AU - Li, Irene

AU - Roberts, Lewis R.

AU - Chan, Christina

N1 - Funding Information: We thank Dr. Melinda Frame at Center for Advanced Microscopy, Michigan State University for assistance with confocal experiments, Dr. Louis King and Christi Harris at Flow Cytometry Core, Michigan State University for assistance with flow cytometry experiments. We thank Catherine D. Moser and Nasra H. Giama at the Mayo Clinic for assistance with the provision of de-identified frozen tissue samples and their corresponding clinical information. This study was supported in part by the National Science Foundation (CBET 0941055) and the National Institutes of Health (R01GM089866 and R21CA176854).

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Hepatocellular carcinoma (HCC) is the second-leading cause of cancer-related death worldwide, and the factors influencing HCC progression are poorly understood. Here we reveal that HCC progression via induction of epithelial-mesenchymal transition (EMT) is closely associated with the expression of CD36/fatty acid translocase and elevated free fatty acid (FFA) levels. Although obesity is manifested as elevated FFA levels, the degree of EMT was not associated with the body mass index of the patients, highlighting the specific roles of CD36 and FFA uptake. Treatment of human liver cancer cell lines with FFAs exacerbated the EMT phenotype, whereas chemical inhibition of CD36 mitigated these effects. Furthermore, the Wnt and TGF-β signaling pathways were activated upon FFA treatment, potentially acting as upstream activators of the EMT program. These results provide the first direct evidence associating CD36 and elevated FFAs with HCC progression.

AB - Hepatocellular carcinoma (HCC) is the second-leading cause of cancer-related death worldwide, and the factors influencing HCC progression are poorly understood. Here we reveal that HCC progression via induction of epithelial-mesenchymal transition (EMT) is closely associated with the expression of CD36/fatty acid translocase and elevated free fatty acid (FFA) levels. Although obesity is manifested as elevated FFA levels, the degree of EMT was not associated with the body mass index of the patients, highlighting the specific roles of CD36 and FFA uptake. Treatment of human liver cancer cell lines with FFAs exacerbated the EMT phenotype, whereas chemical inhibition of CD36 mitigated these effects. Furthermore, the Wnt and TGF-β signaling pathways were activated upon FFA treatment, potentially acting as upstream activators of the EMT program. These results provide the first direct evidence associating CD36 and elevated FFAs with HCC progression.

UR - http://www.scopus.com/inward/record.url?scp=84942902954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942902954&partnerID=8YFLogxK

U2 - 10.1038/srep14752

DO - 10.1038/srep14752

M3 - Article

C2 - 26424075

AN - SCOPUS:84942902954

SN - 2045-2322

VL - 5

JO - Scientific reports

JF - Scientific reports

M1 - 14752

ER -

Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this